Latest filing published 29 Jun 2015 for Zep Inc..
No signal scores available.
Joseph Squicciarino has filed trades across 2 companies (mainly through SEC (Form 4)), most often in King Pharmaceuticals Inc and Zep Inc. We count 47 filings; the first trade dates from 20 March 2006 and the latest from 26 June 2015.
The open-market record consists of 14 sales worth €753k, with no purchase. The rest of the record consists of 26 share grants and 4 option exercises.
The latest filing, published on 29 June 2015, reports a transaction in Zep Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 47 declarations